- Unit:
- SINTEF Industry
- Department:
- Biotechnology and Nanomedicine
- Office:
- Trondheim
I have worked in SINTEF since 2013, and participated and lead projects within a broad field of application: development of cellular models for screening - including advanced 3D-models; biopharmaceutical process development with special focus on mammalian expression systems; process development and assays related to immunotherapy - including cellular therapies; and proteomics research on microorganisms, biomass, virus, host responses, disease models, extracellular vesicles
Education
Master of Technology in Industrial chemistry and biotechnology from NTNU, 2008
PhD in Biomedicine from University of Bergen, 2013
Competence and research areas
Cell culture; primary cells; tissue microenvironment; tumor biology; advanced cell models; extracellular vesicles; bioprocess development; immunotherapy; proteomics; high-throughput screening; biopharmaceuticals.
Projects
Publications
- High-throughput assay for effect screening of amphotericin B and bioactive components on filamentous Candida albicans
- Miniaturization of bioprocess development for immunotherapies
- Miniaturization of bioprocess development for immunotherapies
- Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function
- Identification of novel biomarkers of inflammation in Atlantic salmon (Salmo salar L.) by a plasma proteomic approach
- The Use of Extracellular Membrane Vesicles for Immunization against Francisellosis in Nile Tilapia (Oreochromis niloticus) and Atlantic cod (Gadus morhua L.)
- Alginate Hydrogel Characteristics Regulate Dermal Fibroblasts Biology
- Varying single parameters of the alginate hydrogels to design better microenvironments for fibroblasts cultivation in vitro
- Extracellular vesicles in patients in the acute phase of psychosis and after clinical improvement: an explorative study
- Bridging gaps in the immunotherapeutic research pipeline